Clinical trial
Microwave Ablation of Primary and Secondary Lung Malignancies: A Phase I-II Single Centre Prospective Safety and Efficacy Trial
NCT04369872 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Microwave Ablation of Primary and Secondary Lung Malignancies: A Phase I-II Single Centre Prospective Safety and Efficacy Trial
- Lead sponsor
- University of Calgary
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- May 1, 2020
- Completion date
- December 31, 2022
- Enrollment
- 35 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.